Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency
Open accessAbstract
BACKGROUND: Adjustment of daily hydrocortisone dose on clinical criteria lacks sensitivity for fine tuning. Long term hydrocortisone (HC) over-replacement may lead to increased morbidity and mortality in patients with adrenal insufficiency (AI). Biochemical criteria may help detecting over- or under-replacement but have been poorly evaluated. METHODS: Multicenter, institutional, pharmacokinetic study on ACTH and cortisol plasma profiles during HC replacement in 27 AI patients compared to 29 matched controls. All AI patients were administered HC thrice daily at doses of 6, 10 and 14 mg/m2/d. Blood samples were drawn hourly from 0800h to 1900h. The main outcome measures were: i) plasma peak cortisol and cortisol area under the curve (AUC) in AI patients compared to controls, ii) correlations between cortisol AUC vs single-point cortisol or ACTH decrease from baseline (ΔACTH) and iii) the predictive value of the two latters for obtaining AI patients' cortisol AUC in the control range. RESULTS: Cortisol peaks were observed 1h after each HC intake and a dose response was demonstrated for cortisol peak and cortisol AUC. The comparison of AI patients' cortisol AUC to controls showed that 81.5% AI patients receiving 6mg/m2/d were adequately replaced, whereas most patients receiving higher doses were over-replaced. The correlation coefficient between 1000h/1400h cortisol concentrations and 0800-1900h cortisol AUC were 0.93/0.88 respectively, whereas the 0800-1200h ΔACTH fairly correlated with 0800-1900h cortisol AUC (R = 0.57). ROC curve analysis indicated that the 1000h and 1400h cortisol concentrations best predicted over-replacement. CONCLUSIONS: Patients receiving a 6mg/m2 hydrocortisone daily dose exhibited the most physiological daytime cortisol profile. Single point plasma cortisol correlated with daytime cortisol AUC in AI patients. Although hydrocortisone dose should be currently determined on clinical grounds, our data suggest that single point plasma cortisol may be an adjunct for further hydrocortisone dose adjustment in AI patients.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Patients in Rousseau et al. (2015) received HC doses distributed as 50%, 25%, and 25% across the day.
“While patients in their study received HC doses distributed as 50%, 25%, and 25% across the day, the proposed model achieves the desired cortisol levels by administering doses of medication in a 60%, 20%, and 20% distribution.”
From Model Predictive Controller to Regulate Cortisol Levels in Individuals With Adrenal Insufficiency (2026) · cites this paper as Rousseau et al. (2015)
These simulations are consistent with real patient data from Rousseau et al. (2015).
“These simulations are consistent with real patient data from Rousseau et al. (2015).”
From Model Predictive Controller to Regulate Cortisol Levels in Individuals With Adrenal Insufficiency (2026) · cites this paper as Rousseau et al. (2015)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Arlt, W., & Allolio, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13492-7 · Cited by 819 · see citing works
Premature Mortality in Patients with Addison’s Disease: A Population-Based Study
Bergthorsdottir, R., Leonsson-Zachrisson, M., Odén, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0076 · Cited by 490 · see citing works
Husebye, E. S., Allolio, B., Arlt, W., Badenhoop, K., Bensing, S., Betterle, C., Falorni, A., Gan, E. H., Hulting, A. ‐., Kasperlik‐Zaluska, A., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12162 · Cited by 403 · see citing works
Modified-release hydrocortisone to provide circadian cortisol profiles
Debono, M., Ghobadi, C., Rostami-Hodjegan, A., Huatan, H., Campbell, M. J., Newell-Price, J., Darzy, K., Merke, D. P., Arlt, W., & Ross, R. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2380 · Cited by 322 · see citing works
Hahner, S., Loeffler, M., Fassnacht, M., Weismann, D., Koschker, A.-C., Quinkler, M., Decker, O., Arlt, W., & Allolio, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0685 · Cited by 282 · see citing works
Subjective health status in Norwegian patients with Addison’s disease.
Løvås, K., Loge, J. H., & Husebye, E. S. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01466.x · Cited by 256 · see citing works
Mah, P. M., Jenkins, R. C., Rostami‐Hodjegan, A., Newell‐Price, J., Doane, A., Ibbotson, V., Tucker, G. T., & Ross, R. J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02106.x · Cited by 243 · see citing works
Zelissen, P. M. J., CROUGHS, R. J. M., van Rijk, P. P., & Raymakers, J. A. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-3-199402010-00005 · Cited by 220 · see citing works
Glucocorticoid replacement therapy: are patients over treated and does it matter?
Peacey, S. R., Guo, C., Robinson, A. M., Price, A., Giles, M. A., Eastell, R., & Weetman, A. P. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.780907.x · Cited by 205 · see citing works
Purnell, J. Q., Brandon, D. D., Isabelle, L. M., Loriaux, D. L., & Samuels, M. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030440 · Cited by 199 · see citing works
An assessment of optimal hydrocortisone replacement therapy
Howlett, T. A. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1340955.x · Cited by 169 · cited 3× · see citing works
“Based on this score, Howlett concluded that 20mg was an appropriate starting dose for HC replacement, and that a thrice daily regimen was the most appropriate regimen [8].”
BackgroundPharmacokinetics and Oral Bioavailability of Hydrocortisone
Derendorf, H., Möllmann, H., Barth, J., Möllmann, C., Tunn, S., & Krieg, M. (1991) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1991.tb01906.x · Cited by 168 · see citing works
Arlt, W., Rosenthal, C., Hahner, S., & Allolio, B. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02473.x · Cited by 138 · see citing works
Why is the management of glucocorticoid deficiency still controversial: a review of the literature
Crown, A. L., & Lightman, S. L. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02320.x · Cited by 127 · see citing works
Kraan, G. P. B., Dullaart, R. P. F., Pratt, J. J., Wolthers, B. G., Drayer, N. M., & de Bruin, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4694 · Cited by 120 · see citing works
Corticosteroid Replacement Therapy: Twice Or Thrice Daily?
Groves, R. W., Toms, G. C., Houghton, B. J., & Monson, J. (1988) · Journal of the Royal Society of Medicine · doi:10.1177/014107688808100906 · Cited by 107 · see citing works
Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma
Zueger, T., Kirchner, P., Herren, C., Fischli, S., Zwahlen, M., Christ, E., & Stettler, C. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2432 · Cited by 90 · see citing works
Newell-Price, J. D. C., Whiteman, M. C., Rostami‐Hodjegan, A., Darzy, K. H., Shalet, S. M., Tucker, G. T., & Ross, R. J. M. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03011.x · Cited by 85 · see citing works
Long‐term follow‐up of bone mineral density in Addison's disease
Jódar, E., Valdepeñas, M. P. R., Martínez, G., Jara, A., & Hawkins, F. G. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01761.x · Cited by 84 · see citing works
Bone density and turnover in Addison's disease: effect of glucocorticoid treatment
Valero, M. A., Leon, M. W. D., Valdepeñas, M. P. R., Larrodera, L., López, M., Papapietro, K., Jara, A., & Hawkins, F. G. (1994) · Bone and Mineral · doi:10.1016/s0169-6009(08)80158-4 · Cited by 82 · see citing works
Feek, C. M., Ratcliffe, J. G., Seth, J., Gray, C., Toft, A. D., & Irvine, W. J. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00634.x · Cited by 76 · see citing works
PLASMA ACTH AND CORTISOL PROFILES IN ADDISONIAN PATIENTS RECEIVING CONVENTIONAL SUBSTITUTION THERAPY
Scott, R. S., Donald, R. A., & Espiner, E. A. (1978) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1978.tb01516.x · Cited by 65 · see citing works
Simon, N., Castinetti, F., Ouliac, F., Lesavre, N., Brue, T., & Oliver, C. (2010) · Clinical Pharmacokinetics · doi:10.2165/11531290-000000000-00000 · Cited by 61 · see citing works
Cortisol production rates measured by liquid chromatography/mass spectrometry
Esteban, N. V., & Yergey, A. L. (1990) · Steroids · doi:10.1016/0039-128x(90)90103-i · Cited by 59 · see citing works
Wichers, M., Springer, W., BIDLINGMAIER, F., & Klingmüller, D. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00723.x · Cited by 53 · see citing works
Ragnarsson, O., Mattsson, A. F., Monson, J. P., Filipsson Nyström, H., Åkerblad, A.-C., Kołtowska-Häggström, M., & Johannsson, G. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0397 · Cited by 46 · see citing works
Løvås, K., Thorsen, T. E., & Husebye, E. S. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344183 · Cited by 43 · see citing works
Long-Acting Hydrocortisone for Glucocorticoid Replacement Therapy
Johannsson, G., Nyström, H. F., Bergthorsdottir, R., Lennernäs, H., & Skrtic, S. (2007) · Hormone Research in Paediatrics · doi:10.1159/000110621 · Cited by 23 · see citing works
Behan, L.-A., Kelleher, G., Hannon, M. J., Brady, J. J., Rogers, B., Tormey, W., Smith, D., Thompson, C. J., McKenna, M. J., & Agha, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0596 · Cited by 23 · see citing works
Bliesener, N., Steckelbroeck, S., Redel, L., & Klingmüller, D. (2003) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2003-44292 · Cited by 10 · see citing works
ACTH suppression after oral administration of cortisone in Addisonian and adrenalectomized patients
Aanderud, S., Myking, O. L., & Bassøe, H. H. (1982) · European Journal of Endocrinology · doi:10.1530/acta.0.1000588 · Cited by 4 · see citing works
[How should the plasma ACTH level in treated Addison's disease patients be interpreted?].
Pehuet-Figoni, M., BERTAGNA, X. Y., Girard, F., Bricaire, H., & Jp, L. (1989) · PubMed · Cited by 2 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- [5]Kraan GP, Dullart RP, Pratt JJ, Wolthers BG, Dtayer NM, De Bruin R. The daily cortisol production reinvestigated in healthy men. J Clin Endocrinol Metab. 1998; 83: 1247– 1252. 9543150
- [15]Pehuet-Figoni M, Bertagna X, Girard F, Bricaire H, Luton JP. How to interpret plasma ACTH level in treated Addisonian patients? Ann Endocrinol (Paris). 1989; 50: 54– 57. 2543260
Cited by
Sorted by citations
Mazziotti, G., Formenti, A. M., Frara, S., Roca, E., Mortini, P., Berruti, A., & Giustina, A. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0154 · Cited by 96 · see citing works
Approach to the Patient Treated with Steroidogenesis Inhibitors
Castinetti, F., Nieman, L. K., Reincke, M., & Newell-Price, J. D. C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab122 · Cited by 75 · see citing works
Reincke, M., Albani, A., Assié, G., Bancos, I., Brue, T. C., Buchfelder, M., Chabre, O., Ceccato, F., Daniele, A., Detomas, M., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1088 · Cited by 57 · see citing works
Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency
Oprea, A., Bonnet, N., Pollé, O. G., & Lysy, P. A. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818821294 · Cited by 54 · see citing works
Buning, J. W., Touw, D. J., Brummelman, P., Dullaart, R. P. F., van den Berg, G., van der Klauw, M. M., Kamp, J., Wolffenbuttel, B. H. R., & van Beek, A. P. (2017) · Metabolism · doi:10.1016/j.metabol.2017.02.005 · Cited by 38 · see citing works
The management of glucocorticoid deficiency: Current and future perspectives.
Dineen, R., Martin-Grace, J., Thompson, C., & Sherlock, M. (2020) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/j.cca.2020.03.006 · Cited by 14 · see citing works
Group 4: Replacement therapy for adrenal insufficiency
Castinetti, F., Guignat, L., Bouvattier, C. M., Samara‐Boustani, D., & Reznik, Y. (2017) · Annales d Endocrinologie · doi:10.1016/j.ando.2017.10.007 · Cited by 19 · see citing works
Self-citationDelle Cese, F., Corsello, A., Cintoni, M., Locantore, P., Pontecorvi, A., Corsello, S. M., & Paragliola, R. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.610904 · Cited by 13 · see citing works
de Heide, L. J. M., de Boer, H. H. R., van Borren, M. M. G. J., Emous, M., Aarts, E. O., & de Boer, H. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00239 · Cited by 13 · see citing works
Kusuki, K., Watanabe, S., & Mizuno, Y. (2019) · BMJ Case Reports · doi:10.1136/bcr-2018-228293 · Cited by 9 · see citing works
Adrenal insufficiency, be aware of drug interactions!
Thijs, E., Wierckx, K., Vandecasteele, S. J., & den Bruel, A. V. (2019) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-19-0062 · Cited by 8 · see citing works
National German Audit of Diagnosis, Treatment, and Teaching in Secondary Adrenal Insufficiency
Petersenn, S., Honegger, J. B., & Quinkler, M. O. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-105077 · Cited by 8 · see citing works
Chihaoui, M., Madhi, W., Yazidi, M., Hammami, B., Oueslati, I., Khessairi, N., Grira, W., Bibi, A., Feki, M., & Chaker, F. (2020) · Endocrine · doi:10.1007/s12020-020-02452-9 · Cited by 7 · see citing works
Salivary Cortisol Measurement Contamination After Oral Hydrocortisone: A Randomized Crossover Trial
Chihaoui, M., Mouelhi, Y., Hammami, B., Oueslati, I., Khessairi, N., Chaker, F., Yazidi, M., & Feki, M. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2271-0700 · Cited by 4 · see citing works
Reznik, Y. (2016) · La Presse Médicale · doi:10.1016/j.lpm.2016.05.007 · Cited by 4 · see citing works
Self-citationImproving glucocorticoid replacement in patients with adrenal insufficiency
Johannsson, G. (2016) · Endocrine · doi:10.1007/s12020-016-0929-2 · Cited by 4 · see citing works
Piazzola, C., Dreves, B., Albarel, F., Nakache, J., Morera, J., Joubert, M., Brue, T. C., Reznik, Y., & Castinetti, F. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae174 · Cited by 4 · see citing works
Self-citationNebenniereninsuffizienz und Nebenniereninzidentalome
Pilz, S. (2017) · Wiener klinische Wochenschrift Education · doi:10.1007/s11812-016-0080-2 · Cited by 2 · see citing works
Model Predictive Controller to Regulate Cortisol Levels in Individuals With Adrenal Insufficiency
Joshi, R., Saha, N., Srinivasan, V., Zak, S. H., & Mariash, C. N. (2026) · arXiv
“These simulations are consistent with real patient data from Rousseau et al. (2015).”
Impact d’un traitement glucocorticoïde optimisé sur la qualité de vie des patients addisoniens
Le-Marchand, A., Fourmy, C., Deberles, E., Morello, R., & Reznik, Y. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.07.144
Self-citation[Electrocardiographie changes in connection with tonsillectomy in persons over 50 years old].
Zagorianskaia, M. E., & Kechker, M. I. (1966) · PubMed
- Authors
- Rousseau, E., Joubert, M., Trzepla, G., Parienti, J. J., Freret, T., Vanthygem, M. C., Desailloud, R., Lefebvre, H., Coquerel, A., Reznik, Y., & PHAD Study Group
- Affiliations
- Centre Hospitalier Universitaire de Caen Normandie (FR)
- Centre Hospitalier Universitaire Amiens-Picardie (FR)
- Corresponding author
- Reznik, Yves
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-08-28
- Volume
- 10
- Issue
- 8
- Pages
- e0135975
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4552782
- OpenAlex
- W2130387888
- Cited by
- 20
- References
- 32
- Citations by year
- 2024: 2 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 1 · 2017: 5 · 2016: 3
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Centre hospitalier régional universitaire de Lille
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- adrenal insufficiency, hydrocortisone replacement, serum cortisol, ACTH, dose-response relationship
- MeSH terms
- Adrenal Insufficiency, Adrenocorticotropic Hormone, Adult, Aged, Female, Humans, Hydrocortisone, Male, Middle Aged, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review